(2017) Cardiovascular safety and benefits of GLP-1 receptor agonists
The hypothesis is that GLP-1 co-agonism neutralizes that hyperglycemic effect while preserving glucagon's fat-burning and energy-expenditure benefits
A review conducted by a team of Polish exercise scientists noted that Carnitine preparations administered orally can occasionally cause heart-burn or dyspepsia. However, they went on to give multiple examples of multiple populations taking carnitine for extended periods with no adverse effects
Food and Drug Administration) It cannot tell you where the product is being dispensed from, or it names a pharmacy you cannot verify through a state board
Pilot Phase I clinical trial of methioninase on high-stage cancer patients: rapid depletion of circulating methionine
Humanas 2026 formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
